Wescott Financial Advisory Group’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$265K Buy
754
+54
+8% +$19.3K 0.02% 165
2025
Q4
$229K Buy
+700
New +$222K 0.02% 175
2025
Q2
Sell
-719
Closed -$224K 175
2025
Q1
$224K Buy
+719
New +$212K 0.02% 160
2024
Q4
Sell
-644
Closed -$208K 175
2024
Q3
$208K Hold
644
0.02% 165
2024
Q2
$201K Buy
+644
New +$189K 0.02% 160
2024
Q1
Sell
-772
Closed -$222K 161
2023
Q4
$222K Sell
772
-11
-1% -$3K 0.03% 152
2023
Q3
$210K Buy
+783
New +$195K 0.04% 148
2023
Q2
Sell
-888
Closed -$215K 162
2023
Q1
$215K Buy
+888
New +$218K 0.05% 145

Other funds holding AMGN

Wescott Financial Advisory Group's AMGN Position: Q1 2026 in Review

Wescott Financial Advisory Group increased its Amgen (AMGN) stake by 7.7% in Q1 2026, buying an estimated $19.3K and bringing the position to 754 shares worth $265K. The position accounts for 0.02% of the portfolio, ranked #165.

Wescott Financial Advisory Group first reported a position in AMGN in Q1 2023 and has held it in 8 quarters since. 3,128 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • Wescott Financial Advisory Group held 754 shares of Amgen worth $265K as of Q1 2026.
  • Wescott Financial Advisory Group bought 54 Amgen shares in Q1 2026, an estimated $19.3K.
  • Amgen made up 0.02% of Wescott Financial Advisory Group's portfolio in Q1 2026, its #165 holding.
  • Wescott Financial Advisory Group first reported a position in Amgen in Q1 2023 and has held it in 8 quarters since.
  • 3,128 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Wescott Financial Advisory Group's 13F filing for Q1 2026, filed 12 May 2026.